Actinium Pharmaceuticals, Inc.

ATNMReported to SECin USCIK 0001388320Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 13. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 13
Form 4 lines at Actinium Pharmaceuticals, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Nicholson, C. David—Awardnothing paid94,200 sharesSep 4, 2026Nicholson, C. Davidnothing paidAward · Sep 4Award94,200Sep 4, 2026
Nicholson, C. David—Awardnothing paid62,800 sharesSep 4, 2026Nicholson, C. Davidnothing paidAward · Sep 4Award62,800Sep 4, 2026
Shetty Ajit—Awardnothing paid92,400 sharesSep 4, 2026Shetty Ajitnothing paidAward · Sep 4Award92,400Sep 4, 2026
Shetty Ajit—Awardnothing paid61,600 sharesSep 4, 2026Shetty Ajitnothing paidAward · Sep 4Award61,600Sep 4, 2026
Almenoff June Sherie—Awardnothing paid27,000 sharesSep 4, 2026Almenoff June Sherienothing paidAward · Sep 4Award27,000Sep 4, 2026